UBS Analyst Is Bullish on Eli Lilly, but Novo Nordisk Is Not Necessarily a Value Trap Oct 8, 2026 Life Science
Barclays Initiates Coverage of the U.S. Medical Technology Sector and Says Valuations Have Reached a Ten-Year Low Oct 7, 2026 Life Science
Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day Oct 7, 2026 Life Science
Pfizer’s High Dividend Is Undervalued by the Market, and Investors May Be Facing a Good Opportunity to Position Themselves Oct 6, 2026 Life Science
Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track Oct 2, 2026 Life Science
Lilly and Viking Just Showed the Obesity Market’s Next Phase — and It’s Not About Pounds Sep 30, 2026 Life Science
Competition Fears Are Overblown, and Eli Lilly’s Growth Engine Remains Strong Sep 30, 2026 Life Science
Summit Secures $2 Billion Investment From AstraZeneca, and the Two Parties Will Jointly Develop Anti-Cancer Drugs Sep 28, 2026 Life Science
STAAR Surgical Announces $50 Million Buyback Plan, Stock Soars More Than 7% on Friday Sep 26, 2026 Life Science
Revolution Medicines Receives FDA Breakthrough Designation, Royalty Pharma Offers a Diversified Investment Path Sep 25, 2026 Life Science
AI Finds New Clues for Gene Editing, but It Is Still Far from a “New CRISPR” Sep 23, 2026 Life Science
Positive VK2735 Clinical Data: Can Viking Therapeutics Displace Eli Lilly and Novo Nordisk? Sep 23, 2026 Life Science
Johnson & Johnson Accelerates Divestiture of DePuy Synthes, Investors Optimistic About Streamlined Strategy Sep 22, 2026 Life Science
Eli Lilly Stock Trails the Market, and Its Growth Story Faces a Test Under a High Valuation Sep 21, 2026 Life Science
